Hale et al. hypothesized that elevated endogenous FGF21 levels likely represent a defense mechanism to combat obesity and insulin resistance and that obesity is a state of FGF21 relative deficiency [28]. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.